# Study of the KPCXM18 Injection for Treatment of Acute Ischemic Stroke

Study · id `cardio:ct-nct05745311` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05745311](<https://clinicaltrials.gov/study/NCT05745311>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05745311

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 240 participants.

## Technical summary

Registry record NCT05745311. Randomized; triple masking; primary purpose treatment. Start 2023-03-01 (anticipated); primary completion 2024-05-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 240 participants (planned count; ClinicalTrials.gov record NCT05745311, source copy `cardio:ctgov-nct05745311-2023-02-28`, retrieved 2026-10-26)
- Planned start: 2023-03-01 (anticipated) (ClinicalTrials.gov record NCT05745311, source copy `cardio:ctgov-nct05745311-2023-02-28`, retrieved 2026-10-26)
- Primary completion: 2024-05-01 (anticipated) (ClinicalTrials.gov record NCT05745311, source copy `cardio:ctgov-nct05745311-2023-02-28`, retrieved 2026-10-26)
- Completion: 2024-07-30 (anticipated) (ClinicalTrials.gov record NCT05745311, source copy `cardio:ctgov-nct05745311-2023-02-28`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05745311-2023-02-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study of the KPCXM18 Injection for Treatment of Acute Ischemic Stroke
- Condition: Acute Ischemic Stroke
- Intervention (Drug): The KPCXM18 injection
- Intervention (Drug): Placebo
- Lead sponsor: Kunming Pharmaceuticals, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: 287d374e48998ce2bd51405e4c5b66e247ffb5a2b146d58bae8704235a441009
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
